Efficacy and safety of low-dose ganciclovir preemptive therapy in allogeneic haematopoietic stem cell transplant recipients compared with conventional-dose ganciclovir: a prospective observational study-Reference-Cited by-同舟云学术

Efficacy and safety of low-dose ganciclovir preemptive therapy in allogeneic haematopoietic stem cell transplant recipients compared with conventional-dose ganciclovir: a prospective observational study

Published:2012-02-20 Issue:6 Volume:67 Page:1486-1492
ISSN:1460-2091
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Park So-Youn,Lee Sang-Oh,Choi Sang-Ho,Kim Yang Soo,Woo Jun Hee,Baek Seunghee,Sung Heungsup,Kim Mi-Na,Kim Dae-Young,Lee Jung-Hee,Lee Je-Hwan,Lee Kyoo-Hyung,Kim Sung-Han

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/67/6/1486/16862415/dks043.pdf

Reference24 articles.

1. How we treat cytomegalovirus in hematopoietic cell transplant recipients;Boeckh;Blood,2009

2. Preemptive therapy with ganciclovir 5 mg/kg once daily for cytomegalovirus infection after unrelated cord blood transplantation;Tomonari;Bone Marrow Transplant,2008

3. Cytomegalovirus in hematopoietic stem cell transplant recipients;Ljungman;Infect Dis Clin North Am,2010

4. A survey of allogeneic bone marrow transplant programs in the United States regarding cytomegalovirus prophylaxis and pre-emptive therapy;Avery;Bone Marrow Transplant,2000

5. Neutropenia in allogeneic marrow transplant recipients receiving ganciclovir for prevention of cytomegalovirus disease: risk factors and outcome;Salzberger;Blood,1997

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology, treatment patterns, and disease burden of cytomegalovirus in hematopoietic cell transplant recipients in selected countries outside of Europe and North America: A systematic review;Transplant Infectious Disease;2023-06-08

2. Development of a Vaccine against Human Cytomegalovirus: Advances, Barriers, and Implications for the Clinical Practice;Vaccines;2021-05-25

3. Clinical significance of post-treatment viral load of cytomegalovirus in patients with hematologic malignancies;Journal of Microbiology, Immunology and Infection;2021-04

4. Human cytomegalovirus infection: A considerable issue following allogeneic hematopoietic stem cell transplantation (Review);Oncology Letters;2021-02-23

5. A Systematic Review of the Clinical Pharmacokinetics, Pharmacodynamics and Toxicodynamics of Ganciclovir/Valganciclovir in Allogeneic Haematopoietic Stem Cell Transplant Patients;Clinical Pharmacokinetics;2021-01-30